Cerebriu is a Copenhagen-based clinical AI company developing brain MRI decision support technology for radiology departments and imaging centres worldwide. Its flagship product, Apollo Brain, is a CE-marked Class IIa medical device under MDR 2017/745, purpose-built to automate and optimise MRI workflows at two critical points: scan acquisition and worklist prioritisation. Apollo Acquire detects critical findings in real time during the scan and adapts the MRI protocol accordingly, at the point of acquisition and not retrospectively. Apollo Interpret prioritises radiology worklists by clinical urgency, ensuring the most critical cases reach the right radiologist first. Unlike most radiology AI solutions that operate downstream of the scan, Apollo Brain intervenes during acquisition itself, embedding intelligence directly into the MRI workflow where clinical decisions are still actionable. As an official AI partner of Siemens Healthineers, Apollo Brain is integrated with Siemens MRI systems, giving it direct access to one of the largest installed bases of MRI scanners worldwide. Clinical validation data demonstrates measurable gains in radiology throughput, scan quality, and time-to-diagnosis for high-priority neurological conditions including stroke, tumour, and intracranial haemorrhage. Cerebriu is currently raising a Series B to accelerate commercial deployment across European and international hospital networks.